University of Delaware
Newark, Delaware, 19716, United States
NCT Number: NCT03265353
The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.
Looking for future studies?
Notify Me22 year–45 year
All sexes
Interventional
Not applicable
Newark, Delaware, 19716, United States
Cardiovascular disease remains a major Public Health problem in the U.S. and is the result of diseases such as atherosclerosis and high blood pressure (BP). Several dietary factors have been implicated as risk factors including high sodium and low potassium diets. Indeed, it is well known that excess sodium can increase BP while potassium rich diets have BP lowering properties. While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention. Endothelial dysfunction, characterized by impaired dilation is an important non-traditional risk factor for atherosclerosis. Data in animal models suggest that salt loading, independent of changes in BP, results in endothelial dysfunction while evidence is mounting that potassium may be beneficial to vascular health. Further, potassium may be more effective in the presence of high sodium however the role of potassium in protecting the vasculature from a high sodium diet in salt-resistant adults has not been explored. A potential mechanism responsible for sodium induced vascular dysfunction is overproduction of reactive oxygen species resulting in reduced nitric oxide (NO) production/ bioavailability. It has been suggested that potassium can counteract sodium's effect by reducing ROS. The central hypothesis is that potassium can protect against the deleterious effects of high sodium on the vasculature by reducing oxidative stress and preserving NO. In this grant, the investigators propose to use a 21-day controlled feeding study to compare the effects of a high sodium diet (300 mmol) combined with either a high (120 mmol) or moderate (65 mmol) amount of potassium and low sodium (50 mmol) combined with moderate potassium (crossover design, diet order sequence randomized) on 2 levels of the vasculature, conduit artery and microvasculature. These experiments will be performed in salt-resistant participants to study the vascular effects alone, independent of changes in BP.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
7 days of the prescribed diet
7 days of the prescribed diet
7 days of the prescribed diet
Time frame: on the 7th day of each diet
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
Time frame: on 7th day of each diet
Assessed by carotid to femoral artery pulse wave velocity
Time frame: on 7th day of each diet
Assessed by augmentation index
Time frame: on the 7th day of each diet
Assessed in venous endothelial cells from participants.
Time frame: 7 days
Assessed by 24 hr ambulatory blood pressure monitoring.
University of Delaware
Other
Vascular Effects of Dietary Potassium in Humans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03558893
Cardiovascular Diseases, Cardiovascular Risk Factor
Portland, Oregon, United States
View Trial DetailsNCT03039023
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT04731363
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT03336255
Cardiovascular Risk Factor
Chicago, Illinois, United States
View Trial Details